State-of-the-Art Vaccine Researches
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (1 November 2024) | Viewed by 32147
Special Issue Editors
Interests: vaccines; immunoassays; immunology; serology
* Acting as guest editor in our private capacity.
Interests: vaccines; molecular biology; microbiology
* Acting as guest editor in our private capacity.
Special Issue Information
Dear Colleagues,
Over the the last years, also triggered by the unprecedented public health needs caused by the SARS-CoV-2 pandemic, there has been a renewed interest in different vaccine technologies, and several platforms have been tested in humans and have been immunologically characterised in depth. Indeed vaccines based on the mRNA technology took the center of the scene and represented a game changer for the speed of response to pandemic, however several question marks remain in regards to durability of response and breadth of applicability to bacterial targets. In parellel, extensive and fast growing knowledge was established for novel platforms like protein nanoparticles and viral vectors for DNA delivery as well as for more traditional ones like recombinant proteins and glycoconjugates. Finally, innovative adjuvant systems and alternative delivery were largely investigated to improve the magnitude and quality of the immune response induced by vaccination.
To achieve a more extensive understanding of the progresses made in the vaccine field, this special issue is focused on recent scientific knowledge and current state of the art technologies. Based on your extensive experience, we invite you to contribute with an original research article, report, observation or review, to highlight (i) novel data obtained with state of the art technologies, (ii) comparision of different vaccine platforms in terms of the resulting immunogenicity, (iii) innovative combination of vaccine antigens in high-valency formulations, and (iv) strategies to maximize immune responses against vaccine targets through alternative delivery and adjuvant systems.
We look forward to receiving your contributions.
Dr. Omar Rossi
Dr. Gianmarco Gasperini
Dr. Carlos Giannelli
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccines
- platforms
- immunogenicity
- delivery systsems
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.